benny1985

Teva Pharmaceutical Industries Limited Q1 2009 Earnings Call Transcript

I saw many references to a new Copaxone formulation during this call. TEVA's management said they are working to improve the injection experience. I think it would be interesting to take a look at AIS. They are already working with TEVA on new injectors systems for 5 products, the first one being HGH in the very last stages of an FDA approval. If TEVA is looking for a new injection system for Copaxone, I think its very probable they would go to AIS.
Best,
Ben